Ralph Rogers

1.2k total citations
27 papers, 425 citations indexed

About

Ralph Rogers is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Ralph Rogers has authored 27 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 11 papers in Epidemiology and 9 papers in Oncology. Recurrent topics in Ralph Rogers's work include COVID-19 Clinical Research Studies (6 papers), Cytomegalovirus and herpesvirus research (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Ralph Rogers is often cited by papers focused on COVID-19 Clinical Research Studies (6 papers), Cytomegalovirus and herpesvirus research (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Ralph Rogers collaborates with scholars based in United States. Ralph Rogers's co-authors include Melvin H. Seid, Richard J. Derman, Shaolei Lu, Dimitrios Farmakiotis, Thomas Ollila, Adam J. Olszewski, Reginald Gohh, Adam Zayac, Louis B. Rice and Sophia Koo and has published in prestigious journals such as Blood, Cancer and Clinical Infectious Diseases.

In The Last Decade

Ralph Rogers

26 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralph Rogers United States 10 185 132 102 89 72 27 425
Patricia A. R. Brunker United States 9 67 0.4× 92 0.7× 48 0.5× 32 0.4× 8 0.1× 26 257
Aristotelis Tsiakalos Greece 9 70 0.4× 34 0.3× 13 0.1× 72 0.8× 20 0.3× 21 289
Denise Menezes Brunetta Brazil 11 89 0.5× 171 1.3× 158 1.5× 46 0.5× 7 0.1× 36 379
Bhavna Mahadeb Belgium 10 206 1.1× 187 1.4× 14 0.1× 122 1.4× 17 0.2× 22 380
Maheen Z. Abidi United States 12 250 1.4× 41 0.3× 16 0.2× 237 2.7× 82 1.1× 31 404
Leigh H. Fisher United States 8 115 0.6× 175 1.3× 26 0.3× 218 2.4× 66 0.9× 15 539
Shimin Jasmine Chung Singapore 8 189 1.0× 16 0.1× 17 0.2× 145 1.6× 44 0.6× 45 412
Mohit Chowdhry India 13 93 0.5× 159 1.2× 67 0.7× 159 1.8× 11 0.2× 74 504
Pannee Sirivatanapa Thailand 10 112 0.6× 91 0.7× 112 1.1× 123 1.4× 9 0.1× 20 394
Ann E. Woolley United States 10 231 1.2× 25 0.2× 12 0.1× 114 1.3× 51 0.7× 40 581

Countries citing papers authored by Ralph Rogers

Since Specialization
Citations

This map shows the geographic impact of Ralph Rogers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Rogers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Rogers more than expected).

Fields of papers citing papers by Ralph Rogers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Rogers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Rogers. The network helps show where Ralph Rogers may publish in the future.

Co-authorship network of co-authors of Ralph Rogers

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph Rogers. A scholar is included among the top collaborators of Ralph Rogers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph Rogers. Ralph Rogers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krause, Peter J., et al.. (2024). Tafenoquine for Relapsing Babesiosis: A Case Series. Clinical Infectious Diseases. 79(1). 130–137. 6 indexed citations
2.
Parente, Diane M., Ralph Rogers, Ashlyn Norris, et al.. (2024). Combination of a Rapid Diagnostic Assay and Antimicrobial Stewardship Intervention for Gram-Negative Bacteremia. Open Forum Infectious Diseases. 11(9). ofae477–ofae477. 3 indexed citations
3.
Rogers, Ralph & Louis B. Rice. (2023). Executive Summary: State-of-the-Art Review: Persistent Enterococcal Bacteremia. Clinical Infectious Diseases. 78(1). 1–2. 1 indexed citations
4.
Rogers, Ralph & Louis B. Rice. (2023). State-of-the-Art Review: Persistent Enterococcal Bacteremia. Clinical Infectious Diseases. 78(1). e1–e11. 11 indexed citations
5.
Rogers, Ralph, et al.. (2022). Broad Antimicrobial Resistance in a Case of Relapsing Babesiosis Successfully Treated With Tafenoquine. Clinical Infectious Diseases. 76(4). 741–744. 16 indexed citations
6.
Rogers, Ralph, Basma Merhi, Adena J. Osband, et al.. (2021). Low-Dose Valganciclovir Prophylaxis Is Safe and Cost-Saving in CMV-Seropositive Kidney Transplant Recipients. Progress in Transplantation. 31(4). 368–376. 7 indexed citations
7.
Rogers, Ralph, Basma Merhi, Adena J. Osband, et al.. (2021). Coronavirus Disease 2019 in Kidney Transplant Recipients: Single-Center Experience and Case-Control Study. Transplantation Proceedings. 53(4). 1187–1193. 7 indexed citations
8.
Sam, Soya S., Ralph Rogers, Fizza S. Gillani, et al.. (2021). Evaluation of a Next-Generation Sequencing Metagenomics Assay to Detect and Quantify DNA Viruses in Plasma from Transplant Recipients. Journal of Molecular Diagnostics. 23(6). 719–731. 12 indexed citations
9.
Rogers, Ralph, Kenneth A. Bodziak, Michael Chobanian, et al.. (2021). Implementing a regional standardized BK polyomavirus screening protocol across eleven transplant centres. Transplant International. 34(12). 2680–2685. 2 indexed citations
10.
Ollila, Thomas, et al.. (2021). Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant Disease. JAMA Oncology. 7(11). 1714–1714. 45 indexed citations
11.
Rogers, Ralph, Fadi Shehadeh, Evangelia K. Mylona, et al.. (2020). Convalescent Plasma for Patients With Severe Coronavirus Disease 2019 (COVID-19): A Matched Cohort Study. Clinical Infectious Diseases. 73(1). e208–e214. 35 indexed citations
12.
Naeem, Syed, Reginald Gohh, George Bayliss, et al.. (2020). Successful recovery from COVID‐19 in three kidney transplant recipients who received convalescent plasma therapy. Transplant Infectious Disease. 23(1). e13451–e13451. 24 indexed citations
13.
Farmakiotis, Dimitrios, Ralph Rogers, Adena J. Osband, et al.. (2020). Hyperammonemia syndrome due to Ureaplasma urealyticum in a kidney transplant recipient: A case of disseminated disease from a fluoroquinolone‐resistant isolate. Transplant Infectious Disease. 22(5). e13328–e13328. 9 indexed citations
14.
15.
Shu, Liqi, et al.. (2020). A kidney transplant recipient with nausea, vomiting, and diarrhea after a recent COVID-19 exposure. American Journal of Transplantation. 20(9). 2618–2620.
16.
Adams, Kathleen K., et al.. (2020). Pharmacokinetics of flucytosine in a critically ill patient on continuous venovenous hemodiafiltration. American Journal of Health-System Pharmacy. 77(8). 609–613. 3 indexed citations
17.
Rogers, Ralph, Basma Merhi, Adena J. Osband, et al.. (2020). 576. Half-dose Valganciclovir Prophylaxis is Safe and Cost-effective in CMV Seropositive Renal Transplant Recipients. Open Forum Infectious Diseases. 7(Supplement_1). S352–S353. 1 indexed citations
18.
Rogers, Ralph, Janette Baird, Jun Kit He, Charles A. Adams, & Michael J. Mello. (2014). Using the alcohol, smoking and Substance Involvement Screening Test (ASSIST) to determine substance abuse prevalence in the RI trauma population.. PubMed. 97(2). 42–4. 3 indexed citations
19.
Seid, Melvin H., et al.. (2008). Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology. 199(4). 435.e1–435.e7. 137 indexed citations
20.
Seid, Melvin H., et al.. (2007). 55: Treating postpartum anemia with intravenous ferric carboxymaltose in a randomized controlled study. American Journal of Obstetrics and Gynecology. 197(6). S26–S26. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patricia A. R. Brunker Breakdown of academic impact, for papers by Aristotelis Tsiakalos Breakdown of academic impact, for papers by Denise Menezes Brunetta Breakdown of academic impact, for papers by Bhavna Mahadeb Breakdown of academic impact, for papers by Maheen Z. Abidi Breakdown of academic impact, for papers by Leigh H. Fisher Breakdown of academic impact, for papers by Shimin Jasmine Chung Breakdown of academic impact, for papers by Mohit Chowdhry Breakdown of academic impact, for papers by Pannee Sirivatanapa Breakdown of academic impact, for papers by Ann E. Woolley
Rankless by CCL
2026